Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis
Open Access
- 9 September 2014
- journal article
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 1 (3), 101-105
- https://doi.org/10.5152/eurjrheumatol.2014.034
Abstract
Eurjrheum, ejr, rheumatol, rheumatologyKeywords
This publication has 38 references indexed in Scilit:
- As a New Inflammatory Marker for Familial Mediterranean Fever: Neutrophil-to-Lymphocyte RatioInflammation, 2013
- Clinical Significance of Preoperative Inflammatory Parameters in Gastric Cancer PatientsJournal of Gastric Cancer, 2013
- Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: A promising marker in predicting disease severityClinics and Research in Hepatology and Gastroenterology, 2012
- Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery DiseaseClinical and Applied Thrombosis/hemostasis, 2012
- Neutrophil-Lymphocyte Ratio as a Predictor of Adverse outcomes of Acute PancreatitisPancreatology, 2011
- High intraindividual week-to-week variability in BASDAI and BASFI values: Are several evaluations needed before starting or stopping TNFα antagonist therapy for spondyloarthropathies?Joint Bone Spine, 2008
- Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey.2007
- Staging of patients with ankylosing spondylitis: a preliminary proposalAnnals Of The Rheumatic Diseases, 2002
- The role of tumor necrosis factor in health and disease.1999
- Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.1999